Moreover, a clear trend of increased resistance to hBD-3 of late cystic fibrosis isolates (MBC: 32 mg/L) compared to early ones (MBC: 8 mg/L) was seen in two pairs of isolates: PAFQ11 and PAFQ16 ( Table 1 ).
← all excerpts
<i>In vitro</i> activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants.
1
—
—